Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Ram S, Gill D, Rice PA. Combatting antimicrobial-resistant Neisseria gonorrhoeae: new antibiotics and the pipeline of antigonococcal therapeutics. Curr Opin Infect Dis. 2026 Feb 01; 39(1):36-50.
-
Aamir Hassan M, Abdelaziz M, Noor S, Nangmo Kemda P, Tan A, Park J, Rotello VM. Targeting bacterial biofilms using polymer-stabilized nanoemulsions. Expert Opin Drug Deliv. 2025 Dec; 22(12):1849-1860.
-
Vaughn VM, Horowitz J, Gandhi T, Neetz RA, Petty L, Hersh A, Lindenauer P, Bernstein SJ, Flanders SA, Harrison JD, Smith JD, White AT, Szymczak JE. Developing an approach to enhance recruitment for a cluster-randomised implementation trial: leveraging deliberative participation and credible messengers. BMJ Open. 2025 Sep 16; 15(9):e094925.
-
Noor S, Hassan MA, Aslam MA, Muhammad SA, Quosain Naqvi T, Batool Alvi G, Nagaraj H, Bilal Hussain S, Rotello VM. Fungal Biosystems for the Fabrication of Copper Nanoparticles: An Effective Approach for the Treatment of Bacterial Biofilms. ACS Appl Mater Interfaces. 2025 Jul 30; 17(30):42706-42716.
-
Truong-Bolduc QC, Wang Y, Lawton BG, Zweifach JJ, McDevitt GM, El Abdellaoui Y, Brown Harding H, Yonker LM, Rahme LG, Vyas JM, Hooper DC. NorA and Tet38 efflux pumps enable Staphylococcus aureus survival in the cystic fibrosis airway environment, resistance to antibiotics, and coinfection with Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2025 08 06; 69(8):e0046025.
-
Napier EG, Cinco IR, Wagner SB, Stuart EV, Qiao Q, Taylor J, Stevenson B, Messaoudi I. Borreliosis and doxycycline treatment disrupt gut microbiota and immune responses in nonhuman primates. mBio. 2025 Aug 13; 16(8):e0143725.
-
Pulia MS, Griffin M, Schwei R, Pop-Vicas A, Schulz LT, Shieh MS, Pekow P, Vaughn VM, Lindenauer PK. Antibiotic Treatment in Patients Hospitalized for Nonsevere COVID-19. JAMA Netw Open. 2025 05 01; 8(5):e2511499.
-
Gupta A, Hassan MA, Ndugire W, Park J, Noor S, Nagaraj H, Chakraborty S, Rotello VM. Light-Triggered Bioorthogonal Nanozyme Hydrogels for Prodrug Activation and Treatment of Bacterial Biofilms. ACS Appl Mater Interfaces. 2025 May 07; 17(18):26361-26370.
-
Chiang MC, Clarke BR, Tew GN, Schiffman JD. Antifouling Activity of Bottlebrush Network Hydrogels. ACS Appl Bio Mater. 2025 May 19; 8(5):4200-4208.
-
Russo TA, Broczkowski B, Sallerson S, Knee A, Lorenzo MP. Association Between Erythromycin or Clindamycin Resistance and 30-Day Mortality in Patients With MSSA Bacteremia. J Pharm Pract. 2026 Feb; 39(1):18-24.